Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02274870 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine for Post Operative Pain After Knee Replacement Surgery
A Phase 4 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 65
- Enrollment target
NCT02274870 is a Phase 4 study that has completed, run by Northwell Health. The registered enrollment target is 65 participants.
The verdict
NCT02274870, a Phase 4 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 65 participants
- Enrollment target
Study Summary
Continuous femoral nerve blocks (CFNB) provide effective pain control to patients undergoing total knee replacement (TKR). However the resulting motor blockade can lead to decreased quadriceps muscle strength and delayed functional recovery.The purpose of this study is to compare the effect of Liposome Bupivacaine infiltration into the knee to CFNB on pain control and functional recovery
Interventions
- DRUG Bupivacaine HCl
- DRUG Liposome Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02274870
The ClinicalTrials.gov registry entry for NCT02274870 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine HCl is the first listed.
NCT02274870 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02274870 about?
NCT02274870 is a clinical study titled "Liposomal Bupivacaine for Post Operative Pain After Knee Replacement Surgery". Continuous femoral nerve blocks (CFNB) provide effective pain control to patients undergoing total knee replacement (TKR). However the resulting motor blockade can lead to decreased quadriceps muscle strength and delayed functional recovery.The purpose of this study is to compare the effect of Lipos...
What is the current status of trial NCT02274870?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 65 participants. The study started on 2014-11. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02274870?
The interventions under investigation include: Bupivacaine HCl (DRUG), Liposome Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT02274870?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.